These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 27172295)

  • 41. Nephrotic syndrome secondary to alpha-1 antitrypsin deficiency.
    Santos GF; Ellis P; Farrugia D; Turner AM
    BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33674298
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characteristics of Alpha-1 Antitrypsin-Deficient Individuals in the Long-term Oxygen Treatment Trial and Comparison with Other Subjects with Chronic Obstructive Pulmonary Disease.
    Stoller JK; Aboussouan LS; Kanner RE; Wilson LA; Diaz P; Wise R;
    Ann Am Thorac Soc; 2015 Dec; 12(12):1796-804. PubMed ID: 26653189
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Emphysema and bronchiectasis secondary to alpha-1 antitrypsin deficiency.
    Fahim A; Wilmot R; Hart SP
    J Coll Physicians Surg Pak; 2013 Mar; 23(3):224-5. PubMed ID: 23458051
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PiSZ alpha-1 antitrypsin deficiency (AATD): pulmonary phenotype and prognosis relative to PiZZ AATD and PiMM COPD.
    Green CE; Vayalapra S; Hampson JA; Mukherjee D; Stockley RA; Turner AM
    Thorax; 2015 Oct; 70(10):939-45. PubMed ID: 26141072
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessing the efficacy of Alpha
    Pierce LR
    Heliyon; 2024 Jun; 10(11):e31183. PubMed ID: 38912501
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of augmentation therapy for emphysema associated with α1-antitrypsin deficiency: enough is enough.
    Balbi B; Ferrarotti I; Miravitlles M
    Eur Respir J; 2016 Jan; 47(1):35-8. PubMed ID: 26721962
    [No Abstract]   [Full Text] [Related]  

  • 47. Designing Clinical Trials in "Regular" COPD Versus Alpha-1 Antitrypsin Deficiency-Associated COPD: "More Alike Than Unalike?".
    Stoller JK
    Chronic Obstr Pulm Dis; 2022 Jan; 9(1):95-102. PubMed ID: 34735756
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Are There Differences Between the Available Treatments for Emphysema Associated with Alpha-1 Antitrypsin Deficiency?
    Esquinas C; Miravitlles M
    Arch Bronconeumol (Engl Ed); 2018 Sep; 54(9):451-452. PubMed ID: 29625713
    [No Abstract]   [Full Text] [Related]  

  • 49. Regional lung densities in alpha-1 antitrypsin deficiency compared to predicted values.
    Stoel BC; Stolk J; Bakker ME; Parr DG
    Respir Res; 2019 Feb; 20(1):45. PubMed ID: 30819163
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sanger sequencing solved a cryptic case of severe alpha₁-antitrypsin deficiency.
    Zhan SH; Abboud RT; Jung B; Kuchinka B; Ralston D; Casey B; Mattman A
    Clin Biochem; 2012 Apr; 45(6):499-501. PubMed ID: 22330941
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Alpha-1 Antitrypsin Deficiency: Phenotypes and Quality of Life.
    Stockley RA
    Ann Am Thorac Soc; 2016 Aug; 13 Suppl 4():S332-5. PubMed ID: 27564669
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lung Function and CT Densitometry in Subjects with alpha-1-Antitrypsin Deficiency and Healthy Controls at 35 Years of Age.
    Piitulainen E; Montero LC; Nystedt-Düzakin M; Stoel BC; Sveger T; Wollmer P; Tanash HA; Diaz S
    COPD; 2015 Apr; 12(2):162-7. PubMed ID: 25280185
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Imaging in alpha-1 antitrypsin deficiency: a window into the disease.
    Huang YT; Wencker M; Driehuys B
    Ther Adv Chronic Dis; 2021; 12_suppl():20406223211024523. PubMed ID: 34408834
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema.
    Wewers MD; Casolaro MA; Sellers SE; Swayze SC; McPhaul KM; Wittes JT; Crystal RG
    N Engl J Med; 1987 Apr; 316(17):1055-62. PubMed ID: 3494198
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The national alpha-1 antitrypsin deficiency registry in Poland.
    Chorostowska-Wynimko J; Struniawski R; Sliwinski P; Wajda B; Czajkowska-Malinowska M
    COPD; 2015 May; 12 Suppl 1():22-6. PubMed ID: 25938287
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An overview of alpha-1 antitrypsin deficiency.
    Hericks AJ; Bhat A
    Mo Med; 2007; 104(3):255-9. PubMed ID: 17619502
    [TBL] [Abstract][Full Text] [Related]  

  • 57. α1 Antitrypsin deficiency: current best practice in testing and augmentation therapy.
    Campos MA; Lascano J
    Ther Adv Respir Dis; 2014 Oct; 8(5):150-61. PubMed ID: 25013223
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CT lung densitometry in young adults with alpha-1-antitrypsin deficiency.
    Bernspång E; Diaz S; Stoel B; Wollmer P; Sveger T; Piitulainen E
    Respir Med; 2011 Jan; 105(1):74-9. PubMed ID: 20674322
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Alpha-1-Antitrypsin Deficiency and Bronchiectasis: A Concomitance or a Real Association?
    Sanduzzi A; Ciasullo E; Capitelli L; Sanduzzi Zamparelli S; Bocchino M
    Int J Environ Res Public Health; 2020 Mar; 17(7):. PubMed ID: 32235324
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Results from a large targeted screening program for alpha-1-antitrypsin deficiency: 2003 - 2015.
    Greulich T; Nell C; Herr C; Vogelmeier C; Kotke V; Wiedmann S; Wencker M; Bals R; Koczulla AR
    Orphanet J Rare Dis; 2016 Jun; 11(1):75. PubMed ID: 27282198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.